Clinical Trial Update: Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk [Phase 4]

View source ↗

Summary

A Phase 4 study from Biotronik evaluated combining their home monitoring system with predefined anticoagulation to reduce stroke risk in patients with atrial fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Stroke
• Systemic Embolism

Drugs mentioned

• BIOTRONIK Home Monitoring
• Predefined Anticoagulation

Snippet

Sponsor: Biotronik, Inc. | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 4 | Status: TERMINATED | Results posted: 2014-06-23